Jenkem Technology Co., Ltd. (SHA:688356)

Market Cap	4.91B +40.5%
Revenue (ttm)	328.26M +41.9%
Net Income	72.23M +164.9%
EPS	1.19 +164.5%
Shares Out	60.50M
PE Ratio	68.33
Forward PE	n/a
Dividend	0.15 (0.18%)
Ex-Dividend Date	Jul 11, 2025

Volume	1,143,191
Average Volume	1,166,747
Open	82.80
Previous Close	82.91
Day's Range	81.20 - 85.29
52-Week Range	61.10 - 118.68
Beta	0.80
RSI	28.27
Earnings Date	Apr 29, 2026

About Jenkem Technology

Jenkem Technology Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of medical and pharmaceutical polyethylene glycol derivative (PEG) products in China and internationally. The company offers high molecular weight polyethylene glycol derivatives comprising branched, methoxylated, bifunctionalized, heterofunctionalized disubstituted, multi-arm, multi-arm heterofunctional disubstituted, amino-polyglycolic, N-terminated polyethylene glycol-modified, and thiol-modified polyethylene glycol PEG pro...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2001
• Employees: 269
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688356

Financial Performance

In 2025, Jenkem Technology's revenue was 318.22 million, an increase of 40.13% compared to the previous year's 227.10 million. Earnings were 61.70 million, an increase of 106.78%.